Blake Leitch bought 50,000 shares in research company Xspray Pharma on 28 September, where he is CEO. The shares were purchased at a price of SEK 9.51 per share. The purchase amount totals SEK 475,337.
This is shown in the Swedish Financial Supervisory Authority’s insider register.
According to the shareholder service Holding, Leitch now holds 100,000 shares in the company.
